Continuing education · Psychedelic-assisted therapy

The bridge between psychedelic research and clinical practice.

A rigorous, interdisciplinary training pathway for the clinicians shaping the next era of mental-health care, grounded in pharmacology, psychotherapy, ethics, and supervised practice.

CE / CME credits eligible8 disciplines served

Positioning

The therapeutic potential of psilocybin, MDMA, and ketamine is no longer fringe. It is an active frontier of psychiatric medicine. What clinicians need now is not more enthusiasm, but a structured pathway that integrates science, medicine, and healing into a single coherent training.

Evidence-informed. Supervised. Interdisciplinary by design.

Who this is for

Eight disciplines, one shared standard of care.

See tailored pathways
01

Psychiatrists

Prescribing frameworks, screening, and risk stratification for ketamine and trial-phase compounds.

02

Primary-care physicians

Recognize candidacy, manage comorbidity, and coordinate referral within scope of practice.

03

Registered nurses

Session monitoring, physiological safety, and dosing-day care protocols.

04

Social workers

Preparation, integration therapy, and psychosocial support across the arc of care.

05

Researchers

Trial design literacy, outcome measures, and translation of findings into practice.

06

Palliative-care specialists

Existential distress protocols and end-of-life applications with medical fragility in mind.

07

Indigenous leaders & healers

Reciprocal dialogue on lineage, ceremony, and consent in clinical settings.

08

Underground practitioners

Harm reduction, ethics, boundaries, and pathways toward regulated practice.

The pathway

One baseline, seven domains of practice.

See full curriculum

Modalities

Three compounds. Three very different clinical realities.

C12H17N2O4P

Psilocybin

Studied primarily in depression and end-of-life distress. We cover the current evidence base, session structure, and the screening that keeps participants safe.

C11H15NO2

MDMA

Trauma-focused protocols with a strong emphasis on cardiovascular screening, dyad therapy models, and evolving regulatory status.

C13H16ClNO

Ketamine

The one modality already in widespread clinical use. Routes of administration, monitoring standards, and integration between sessions.

CE / CME credits

Credit that holds up to your licensing board.

Coursework is delivered in live grand-rounds sessions and self-paced modules. Credit eligibility varies by discipline and jurisdiction; each session lists its designation before you register.

  • Up to 64 hrs

    AMA PRA Category 1

    Physicians

  • Up to 64 hrs

    ANCC Contact Hours

    Registered nurses

  • Up to 48 hrs

    ASWB ACE

    Social workers

  • Up to 48 hrs

    APA Continuing Education

    Psychologists

See accreditation details

Our approach

Safety First

Patient safety, clinical rigor, and ethical integrity govern every module, every practicum hour, and every case discussion.

Evidence-Informed

We teach from the best available research and name its limits plainly, leaving room for inquiry, debate, and new findings.

Community & Collaboration

Better care emerges when clinicians, researchers, educators, and traditional practitioners learn across disciplines together.

Live grand rounds

Case-based sessions, every other week.

View all events
  • SEP 18

    2026

    Screening for cardiovascular risk in MDMA protocols

    Dr. Amara Osei, MD

  • OCT 02

    2026

    Integration therapy: what happens in week three

    Rowan Vasquez, LCSW

  • OCT 23

    2026

    Consent, touch, and power in psychedelic care

    Dr. Hana Petrov, PhD

Faculty

Taught by people who do the work.

Meet the faculty

Dr. Amara Osei

MD, FRCPC

Psychiatry, trial safety

Rowan Vasquez

LCSW

Preparation & integration

Dr. Hana Petrov

PhD

Ethics & consent

Dr. Elias Mbeki

MD

Ketamine practice

Outcomes

The practicum was the part I could not get anywhere else. Reading trial data is one thing; sitting with a patient through hour four is another.

Dr. Priya Raman

MD, Consultation-liaison psychiatry

It treated me as a clinician, not a convert. The ethics module alone reshaped how our team writes consent.

Marcus Delaney

LCSW, Community mental health

The interdisciplinary rooms were the point. I learned as much from the palliative nurses as from the pharmacology faculty.

Dr. Yuki Tanaka

PhD, Clinical research

The library

Reading, listening, and clinic-ready protocols.

Browse resources
Methods9 min

What 'evidence-based' actually means in psychedelic care

PharmacologyCurated

Twelve papers every prescribing clinician should know

Ethics52 min

Grand Rounds, Ep. 14: Boundaries in non-ordinary states

Train for the practice you will actually be doing in five years.

Applications reviewed on a rolling basis · Next cohort begins April